Page last updated: 2024-09-05

cgp 54626 and dihydroxyphenylalanine

cgp 54626 has been researched along with dihydroxyphenylalanine in 1 studies

Compound Research Comparison

Studies
(cgp 54626)
Trials
(cgp 54626)
Recent Studies (post-2010)
(cgp 54626)
Studies
(dihydroxyphenylalanine)
Trials
(dihydroxyphenylalanine)
Recent Studies (post-2010) (dihydroxyphenylalanine)
570168,823322833

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bettler, B; Bräuner-Osborne, H; Cryan, JF; Froestl, W; Kaupmann, K; Klebs, K; Mombereau, C; Mosbacher, J; Sansig, G; Schmutz, M; van der Putten, H; Waldmeier, P; Wellendorph, P1

Other Studies

1 other study(ies) available for cgp 54626 and dihydroxyphenylalanine

ArticleYear
Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
    The European journal of neuroscience, 2003, Volume: 18, Issue:10

    Topics: 4-Butyrolactone; Adjuvants, Anesthesia; Animals; Anticonvulsants; Autoradiography; Baclofen; Behavior, Animal; Benzocycloheptenes; Binding, Competitive; Body Weight; Brain; Cell Membrane; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Electroencephalography; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Guanosine 5'-O-(3-Thiotriphosphate); Mice; Mice, Inbred BALB C; Mice, Knockout; Motor Activity; Organophosphorus Compounds; Phenols; Radioligand Assay; Receptors, GABA-B; Sodium Oxybate; Time Factors

2003